Back to results
US 2026/0062399 A1Published application
Substituted ethylamine fused heterocyclic mescaline derivatives
AssigneeEnveric Biosciences Canada Inc.
InventorsKaveh Matinkhoo, David James Press, Jessica Bik-jing Lee, Ye Cai, Jillian M. Hagel, Peter J. Facchini
Life of this patent
Estimating the term…
Abstract
Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
Claims20
A compound having chemical formula (I) or (II):
- wherein, in chemical formula (I) or (II):
- X1, X2, and X3 are a hydrogen atom or an O-alkyl group;
- X4 is an alkylene group;
- R1′ and R1″ are joined together to form an oxo group (C═O);
- R2 is an alkyl group;
- R1a and R1b are each independently selected from an alkyl group, a hydroxylalkyl group, an optionally substituted alkyl-aryl group, or a hydrogen atom (H), or R1a and R1b are joined together, along with the nitrogen atom to which they are attached, to form a 3-10-membered optionally substituted heterocyclic ring;
- and
- wherein, optionally, the amino group (—NR1aR1b) is protonated to form (—N+HR1aR1b), and chemical formula (I) or (II) further include a negatively charged anion balancing the positively charged nitrogen atom.
5 more elements
Dependencies are inferred from the claim text.